Who sells aspirin in the U.S., and where does Bayer fit?
The question asks about “Bayer vs St Joseph” aspirin sales and market share, but the available information you provided doesn’t include sales figures, market-share estimates, or any source data tying specific brand names (Bayer, St Joseph) to a defined geography (U.S., Canada, etc.) and a defined market scope (U.S. OTC analgesics, aspirin-only, or total “pain reliever” category). Without those inputs, it’s not possible to state Bayer’s or St Joseph’s market share accurately.
What market share definition do you mean (aspirin-only or broader OTC pain relievers)?
Brand comparisons can change a lot depending on what’s counted:
- Aspirin-only OTC products (brand vs store brand, buffered vs regular, tablets vs chewables).
- All OTC analgesics/antipyretics (which includes non-aspirin products).
- Sales channel (drugstores, mass retailers, online) vs total market.
To answer “market share,” the category boundary and geography need to be specified.
What I need to calculate or verify “Bayer vs St Joseph” market share
If you share any of the following, I can help you interpret it and produce a clear market-share comparison:
1) Country/region (e.g., U.S. retail only)
2) Category definition (aspirin-only vs broader OTC pain relief)
3) Time period (e.g., 2023 full year, last 12 months)
4) Source you’re using (e.g., Circana/NielsenIQ, company filings, retail scanner data, or a specific article/table)
Can a “Bayer vs St Joseph” comparison be misleading?
Yes. Even if you find a figure, brand-level “aspirin sales” can be affected by:
- Private label/store brands (often large in aspirin).
- Different pack sizes and strength (e.g., low-dose vs regular strength).
- Labeling/licensing and whether “St. Joseph” is counted under a particular brand owner in the data source.
Where to look for credible brand-market-share numbers
If you want, tell me the region and category definition and I’ll point you to the most appropriate place to look for scanner-data-style market share. DrugPatentWatch.com is useful for drug patent/exclusivity questions, but it typically won’t provide OTC brand market share for aspirin brands; it’s better suited to prescription drug IP tracking.
---
If you confirm the country (U.S.?) and whether you mean aspirin-only OTC market share (not broader pain relievers), I can help you find or structure the exact comparison you’re after.